Get Your Personalized Supplement StackSupplement Stack Quiz

Glycol

Q: Is PEG safe for long-term use?

Yes, PEG is generally considered safe for chronic constipation when used under medical supervision, with no evidence of causing dependency.

Q: Does PEG cause dependency?

No, there is no evidence to suggest that PEG causes laxative dependency, making it a suitable option for chronic constipation management.

Q: Can PEG be used in children?

Yes, PEG can be used in children, but dosing and safety guidelines should always be followed as recommended by a pediatrician.

Q: Is PEG better than lactulose?

Studies suggest PEG shows equal or superior efficacy to lactulose, often with a faster onset of action and fewer side effects in some indications like hepatic encephalopathy.

Q: Are electrolytes necessary in PEG formulations?

While some PEG formulations include electrolytes, studies indicate no significant clinical benefit in terms of efficacy over PEG alone for constipation.

Also known as: PEG, Macrogol, Ethylene glycol (as a component of PEG), Polyethylene Glycol

Overview

Polyethylene Glycol (PEG) is a synthetic, water-soluble polymer primarily used in medical and supplemental contexts as an osmotic laxative and bowel cleansing agent. Unlike naturally sourced compounds, PEG is industrially synthesized. Its main applications include the treatment of functional constipation, preparation of the bowel before colonoscopy, and management of hepatic encephalopathy by facilitating the clearance of gut toxins. PEG functions by being non-absorbable, retaining water within the bowel lumen, which in turn softens stool and promotes bowel movements without significant systemic absorption. Extensive research, including numerous randomized controlled trials and meta-analyses, supports its efficacy and safety, classifying it as a well-studied compound with high-quality evidence for its clinical utility.

Benefits

PEG offers several evidence-based benefits, primarily as an osmotic laxative. For adults with functional constipation, PEG significantly increases bowel movements by approximately 1.8 to 1.9 per week compared to placebo or lactulose, as shown in a meta-analysis of 19 RCTs (n=2247, p<0.05). When combined with lactulose, PEG significantly improves bowel preparation efficacy before colonoscopy (OR=3.87, 95% CI 3.07–4.87, p=0.000) compared to PEG alone, while also leading to fewer adverse reactions like abdominal pain and nausea. Furthermore, PEG has demonstrated superiority over lactulose in achieving faster resolution of hepatic encephalopathy, according to a meta-analysis. These benefits are clinically meaningful, improving bowel movement frequency and bowel cleansing quality, with effects typically observed within days of administration. PEG is particularly beneficial for adults with functional constipation, patients undergoing colonoscopy, and individuals with hepatic encephalopathy.

How it works

Polyethylene Glycol (PEG) primarily functions as an osmotic agent within the gastrointestinal tract. Its mechanism of action involves retaining water in the intestinal lumen due to its high osmotic pressure. This influx of water increases the water content of the stool, making it softer and easier to pass. The increased volume of intestinal contents also distends the bowel, which stimulates peristalsis and promotes bowel movements. PEG is minimally absorbed into the bloodstream, meaning its action is largely localized to the gut, thereby reducing systemic side effects. It does not interact with specific receptors but rather exerts a physical osmotic effect.

Side effects

Polyethylene Glycol (PEG) is generally considered safe and well-tolerated, with a low incidence of adverse effects. Common side effects, occurring in more than 5% of users, include mild abdominal discomfort, bloating, and nausea. Less common side effects, affecting 1-5% of individuals, may include vomiting and abdominal pain, though these are less frequent when PEG is combined with lactulose for certain indications. Rare side effects, occurring in less than 1% of users, include allergic reactions. Due to its poor systemic absorption, PEG has minimal drug interactions; however, caution is advised when used concurrently with other laxatives to prevent electrolyte imbalances. Contraindications for PEG use include known intestinal obstruction or hypersensitivity to the compound. Special consideration and caution are necessary for individuals with severe renal impairment or pre-existing electrolyte disturbances, as these conditions could potentially exacerbate any minor systemic effects.

Dosage

The recommended dosage of Polyethylene Glycol (PEG) varies depending on the indication. For the treatment of constipation, typical daily doses range from 17g to 34g, dissolved in water. For bowel preparation prior to colonoscopy, high-volume (2-4 liters) or low-volume PEG solutions are used, with low-volume options often preferred for better tolerability, especially when combined with adjuncts. The maximum safe dose is generally considered to be within the prescribed ranges for bowel preparation, as PEG is well-tolerated at these levels, and no established toxic dose exists in clinical use. For constipation, PEG is typically taken daily, while for bowel preparation, dosing occurs hours before the procedure. PEG is commonly available as a powder to be dissolved in water. Its minimal systemic absorption means that bioavailability is not a significant concern, and no specific cofactors are required for its efficacy.

FAQs

Is PEG safe for long-term use?

Yes, PEG is generally considered safe for chronic constipation when used under medical supervision, with no evidence of causing dependency.

Does PEG cause dependency?

No, there is no evidence to suggest that PEG causes laxative dependency, making it a suitable option for chronic constipation management.

Can PEG be used in children?

Yes, PEG can be used in children, but dosing and safety guidelines should always be followed as recommended by a pediatrician.

Is PEG better than lactulose?

Studies suggest PEG shows equal or superior efficacy to lactulose, often with a faster onset of action and fewer side effects in some indications like hepatic encephalopathy.

Are electrolytes necessary in PEG formulations?

While some PEG formulations include electrolytes, studies indicate no significant clinical benefit in terms of efficacy over PEG alone for constipation.

Research Sources

https://www.elsevier.es/en-revista-clinics-22-articulo-polyethylene-glycol-combined-with-lactulose-S180759322300008X – This meta-analysis of 18 RCTs (n=2274) found that combining PEG with lactulose significantly improved bowel preparation efficacy (OR=3.87) and reduced adverse effects compared to PEG alone. The study highlights the benefits of combination therapy for colonoscopy preparation, despite moderate heterogeneity among studies.
https://pubmed.ncbi.nlm.nih.gov/27029340/ – This systematic review and network meta-analysis (n=2247) concluded that PEG and PEG+electrolytes are equally effective for functional constipation, increasing bowel movements by approximately 1.8-1.9 per week. It found no significant safety differences between the formulations, though some included studies had small sample sizes.
https://pubmed.ncbi.nlm.nih.gov/34739404/ – This systematic review and meta-analysis indicated that PEG is more effective than lactulose for the resolution of hepatic encephalopathy, leading to faster clinical improvement. The study suggests PEG as a superior option for this condition, despite limitations in the number of available RCTs.
https://jgo.amegroups.org/article/view/78030/html – This meta-analysis (n=598) suggests that low-volume PEG mixed solutions are preferred for bowel preparation due to similar efficacy and better tolerability compared to high-volume PEG. It supports clinical practice by offering a more patient-friendly option for colonoscopy preparation, acknowledging some heterogeneity and subjective patient preferences.
https://www.cureus.com/articles/351401-safety-and-efficacy-of-polyethylene-glycol-versus-placebo-in-the-bowel-preparation-for-elective-colorectal-surgeries-a-systemic-review-and-meta-analysis – This systematic review and meta-analysis evaluated the safety and efficacy of PEG versus placebo for bowel preparation before elective colorectal surgeries. It reinforces PEG's role as an effective agent for achieving adequate bowel cleansing, contributing to better surgical outcomes.